Sparrow BioAcoustics Secures $10 Million to Support Expanding U.S. Deployment of Smartphone-Based Cardiac AI

Funding Rounds

▤ Summary

Sparrow BioAcoustics closed a $10 million financing round led by Killick Capital and Klister Credit, with additional backing from several investors. The company will use the capital to expand deployment of its FDA-cleared Stethophone platform across U.S. hospitals. Stethophone uses smartphone-based cardiac AI to detect structural and rhythm-related heart anomalies. The company says the platform is already being evaluated at multiple clinical sites and has been used by about 40,000 patients and practitioners. Recent study results and upcoming conference appearances add more momentum to the rollout.

$ Funding

$
Amount $10.0M Total raised
□
Date October 29, 2025 Announcement date
◎
Investors Killick Capital, Klister Credit Lead investors
▥
Company sparrowbioacoustics.com Funded company

▥ Classifications

industries
HealthTech
applications
AI & Machine learning

◇ AskAI Classifications

Labels
Medical Software Digital Health SaaS

▦ Linked Companies